Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Li, Lianhong  [Clear All Filters]
Journal Article
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, et al. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer. Cancer Lett. 2019.
Lu Y, Zhang C, Li Q, Mao J, Ma W, Yu X, Hou Z, Li L. [Inhibitory effect of salinomycin on human breast cancer cells MDA-MB-231 proliferation through Hedgehog signaling pathway]. Zhonghua Bing Li Xue Za Zhi. 2015;44(6):395-398.
Wu D, Zhang J, Lu Y, Bo S, Li L, Wang L, Zhang Q, Mao J. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. Cancer Gene Ther. 2018.
Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu Y, Li J, Zhang Q, Li Q, Li L. Retraction notice to "MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin" [Biomed. Pharmacother. 77 (2016) 135-141]. Biomed Pharmacother. 2023:115372.
Liu L, Wang Q, Mao J, Qin T, Sun Y, Yang J, Han Y, Li L, Li Q. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem Biol Interact. 2018.
Zhang C, Lu Y, Li Q, Mao J, Hou Z, Yu X, Fan S, Li J, Gao T, Yan B, et al. Salinomycin Suppresses TGF-β1-Induced Epithelial-to-Mesenchymal Transition in MCF-7 Human Breast Cancer Cells. Chem Biol Interact. 2016.